Metagenomi Therapeutics, Inc. (MGX) Net margin 2023–2025
Metagenomi Therapeutics, Inc. (MGX) net profit margin by fiscal year — reported net income divided by reported revenue.
-348.5%FY2025 · since FY2023: -152.5% → -348.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -348.5% | -199.3 pp |
| FY2024 | -149.3% | +3.2 pp |
| FY2023 | -152.5% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice